McKesson Corporation (MCK) compared with its closest peers (COR, CAH, CI, SYY, MDLN): P/E 23.5 vs industry 23.9. Peer set by Wholesale; 10 comparable wholesalers. First-party data.
Cencora and Cardinal Health: named a competitor in the 10-K; Cigna, Sysco, Medline, Henry Schein and Amneal Pharmaceuticals share McKesson's business model, drug distributor / pharmaceutical wholesale.
| Company | Market Cap | P/E |
|---|---|---|
| Cencora, Inc. (COR) | $64.19B | 24.5 |
| Cardinal Health, Inc. (CAH) | $57.10B | 34.4 |
| Cigna Corporation (CI) | $74.72B | 12.0 |
| Sysco Corporation (SYY) | $39.10B | 22.3 |
| Medline Inc. (MDLN) | $31.24B | 30.5 |
| TD SYNNEX Corporation (SNX) | $20.34B | 17.9 |
| Henry Schein, Inc. (HSIC) | $10.07B | 25.0 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $5.76B | 36.6 |
| Ryerson Holding Corp (RYZ) | $1.37B | — |
| ScanSource, Inc. (SCSC) | $1.14B | 14.4 |
| Stock P/E | 23.5 |
| Sector P/E (Consumer Discretionary) | 20.1 |
| Industry P/E (Wholesale) | 23.9 |
| vs Sector | 16.7% |
| vs Industry | -1.6% |
MCK overview · MCK earnings · MCK financials · MCK KPIs · MCK documents · MCK ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.